Research Keyword: fear conditioning

Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa

mycolabadmin

Two patients with severe anorexia nervosa received psilocybin-assisted therapy and unexpectedly recovered memories of sexual assault that had been unconsciously suppressed. Processing these traumatic memories with professional support led both patients to achieve remission from their eating disorders within three months. This case report suggests that psilocybin may help unlock and heal deeply buried trauma underlying eating disorders, though more research is needed to understand how this works and ensure patient safety.

Read More »

Investigating the Potential of Psilocybin for Compulsive Eating in a Rat Model of Binge Eating

mycolabadmin

Researchers tested whether psilocybin, a psychedelic compound from magic mushrooms, could help reduce compulsive eating in rats bred to binge eat high-fat, high-sugar foods. Using a fear-conditioning experiment, they found that a single dose of psilocybin did not reduce the rats’ compulsive eating behavior at the dosage tested. However, the treatment may have affected fear-related freezing responses, suggesting psilocybin might influence brain circuits involved in learning and memory.

Read More »

New Positive TRPC6 Modulator Penetrates Blood–Brain Barrier, Eliminates Synaptic Deficiency and Restores Memory Deficit in 5xFAD Mice

mycolabadmin

Researchers developed a new drug candidate called C20 that activates TRPC6 proteins in the brain. In studies with Alzheimer’s disease mouse models, C20 protected nerve connections from damage, restored memory function, and successfully crossed the blood-brain barrier. The compound shows promise as a potential treatment for Alzheimer’s disease by strengthening the connections between brain cells that are damaged in the disease.

Read More »
Scroll to Top